Daniel P. Getman, Ph.D.
Director, Board of Directors
Dr. Getman has been a Director of Sucampo since September 2011. He served as our Chairman from March 2014 to January 2016. He served as the President of Kansas City Area Life Sciences, Inc. (KCALSI), from 2009 until his retirement in July 2012. Dr. Getman joined KCALSI from Pfizer, Inc., where he had been Vice President of Global Research and Development and Director of Pfizer’s St. Louis laboratories from 2003 to 2008; Dr. Getman also served on Pfizer’s external research network committee, responsible for the Midwest region. Prior to joining Pfizer, Dr. Getman worked at Pharmacia Corporation, which merged with Pfizer in 2003, and G.D. Searle & Company and Monsanto Company.
Dr. Getman’s own research experience spans medicinal chemistry in the areas of arthritis, cancer and infectious diseases, including a large program with G.D. Searle/Monsanto before its merger with Pharmacia, on HIV Protease Inhibitors for AIDS that led to three separate licensing deals and two marketed products for AIDS patients – Lexiva® and Prezista®. He also serves as a member of the National Council for the Washington University School of Medicine, is a member of the Board of Managers for the Children’s Discovery Institute at Children’s Hospital/Washington University School of Medicine, and is an adviser to the Wisconsin Alumni Research Foundation catalyst accelerator program.
Dr. Getman earned a bachelor’s degree in chemistry from State University New York Buffalo and a doctorate in organic chemistry from the University of Minnesota.